Effective treatments for paronychia caused by oncology pharmacotherapy

Hiroyuki Goto1,2, Shusuke Yoshikawa1, Keita Mori3

  • 1Department of Dermatology, Shizuoka Cancer Center, Shizuoka, Japan.

The Journal of Dermatology
|November 25, 2015
PubMed

Insights

Paronychia, a painful side effect of molecular-targeted cancer drugs, significantly impacts quality of life. Corticosteroid ointment and phenol chemical matricectomy were found to be effective treatments for this condition.

Area of Science:

  • Oncology
  • Dermatology
  • Pharmacology

Background:

  • Cutaneous adverse events are common with molecular-targeted drugs.
  • Paronychia, a nail fold inflammation, causes pain and can disrupt cancer treatment.
  • Effective treatments for severe paronychia are limited.

Purpose of the Study:

  • To evaluate treatment experiences for paronychia in patients undergoing oncology pharmacotherapy.
  • To identify effective interventions for paronychia to maintain quality of life and treatment continuity.

Main Methods:

  • Review of various treatment methods applied to paronychia.
  • Analysis of outcomes for corticosteroid ointment and phenol chemical matricectomy.

Main Results:

  • Various treatments were attempted for paronychia.
  • Corticosteroid ointment and phenol chemical matricectomy showed significant improvement.
  • These treatments helped patients continue their anticancer therapy.

Conclusions:

  • Dermatologists should employ effective treatments for paronychia.
  • Appropriate management of paronychia is crucial for patient quality of life.
  • Timely intervention enables uninterrupted anticancer drug treatment.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Therapies02:49

Cancer Therapies

3.0K
Hand hygiene01:23

Hand hygiene

Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
6.6K
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
599
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
566
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
42